Skip to main content
Premium Trial:

Request an Annual Quote

Cellink: Ido Amit

Cellink said that Ido Amit is joining the company's scientific advisory board. Amit is a researcher in the Immunology Department at the Weizmann Institute of Science in Israel, where he also earned his PhD in biological regulation. He was a postdoctoral fellow at the Broad Institute at Harvard University and the Massachusetts Institute of Technology. Amit's expertise is in the area of single-cell genomic technologies and their application to characterize the immune system, and as such he will guide Cellink's efforts to build a strong product portfolio for single-cell omics analysis, the company said.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.